Share on LinkedInShare on LinkedIn

ARTICLE · 15 MAY 2023

Another Letter From Congress Complaining About Pharmaceutical Patents

On April 26, 2023, Senator Elizabeth Warren and Congresswoman Pramila Jayapal sent a letter to USPTO Director Kathi Vidal complaining about the USPTO's failure "to address the pharmaceutical industry's abuse...

United StatesIntellectual Property

On April 26, 2023, Senator Elizabeth Warren and Congresswoman Pramila Jayapal sent a letter to USPTO Director Kathi Vidal complaining about the USPTO's failure "to address the pharmaceutical industry's abuse of the patent system." Frustrated by the USPTO's apparent willingness to grant "excessive patents because of the revenue it collects from patent issuance fees," the letter provides "specific recommendations, to urge the USPTO to take immediate action and do everything in its power to hold prescription drug companies accountable for their greedy business practices."

The Warren-Jayapal Recommendations

The letter outlines the following six proposals for the USPTO's consideration:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from